Your browser doesn't support javascript.
loading
Is it possible to claim or refute sputum eosinophils ≥ 3% in asthmatics with sufficient accuracy using biomarkers?
Demarche, Sophie F; Schleich, Florence N; Paulus, Virginie A; Henket, Monique A; Van Hees, Thierry J; Louis, Renaud E.
  • Demarche SF; Department of Respiratory Medicine, CHU Liege, GIGA I3 Research Group, University of Liege, Liege, Belgium. Sophie.Demarche@ulg.ac.be.
  • Schleich FN; Department of Clinical Pharmacy, Center for Interdisciplinary Research on Medicines, University of Liege, Liege, Belgium. Sophie.Demarche@ulg.ac.be.
  • Paulus VA; Department of Respiratory Medicine, CHU Liege, GIGA I3 Research Group, University of Liege, Liege, Belgium.
  • Henket MA; Department of Respiratory Medicine, CHU Liege, GIGA I3 Research Group, University of Liege, Liege, Belgium.
  • Van Hees TJ; Department of Respiratory Medicine, CHU Liege, GIGA I3 Research Group, University of Liege, Liege, Belgium.
  • Louis RE; Department of Clinical Pharmacy, Center for Interdisciplinary Research on Medicines, University of Liege, Liege, Belgium.
Respir Res ; 18(1): 133, 2017 07 03.
Article en En | MEDLINE | ID: mdl-28673351

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Asma / Esputo / Eosinófilos Tipo de estudio: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2017 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Asma / Esputo / Eosinófilos Tipo de estudio: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2017 Tipo del documento: Article